Effect of chronic intermittent hypoxia on theophylline metabolism in mouse liver

Chinese Medical Journal

Volumn 126, Issue 1, 2013, Pages 118-123

  Chen, Xiao Yang ^a   Zeng, Yi Ming ^a   Zhang, Yi Xiang ^a   Wang, Wan Yu ^a   Wu, Run Hua ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hypoxia; Liver; Metabolism; Sleep apnea syndrome; Theophylline

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLECYSTOKININ OCTAPEPTIDE; CYTOCHROME P450; THEOPHYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; DRUG METABOLISM; EDEMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER CELL; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; ROUGH ENDOPLASMIC RETICULUM; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANOXIA; CHRONIC DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; HEPATOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; THEOPHYLLINE;

EID: 84874345270     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20120992     Document Type: Article

References (36)

1. Korcarz CE, Gepner AD, Peppard PE, Young TB, Stein JH. The effects of sleep-disordered breathing on arterial stiffness are modulated by age. Sleep 2010; 33: 1081-1085.
2. Johnson KG, Johnson DC. Obstructive sleep apnea is a risk factor for stroke and atrial fibrillation. Chest 2010; 138: 239.
3. Trombetta IC, Somers VK, Maki-Nunes C, Drager LF, Toschi-Dias E, Alves MJ, et al. Consequences of comorbid sleep apnea in the metabolic syndrome-implications for cardiovascular risk. Sleep 2010; 33: 1193-1199.
4. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 2007; 41: 918-921.
5. Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005; 33: 100-104.
6. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007; 45: 1007-1013.
7. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2007; 293: G871-G877.
8. Feng SZ, Tian JL, Zhang Q, Wang H, Sun N, Zhang Y, et al. An experimental research on chronic intermittent hypoxia leading to liver injury. Sleep Breath 2011; 15: 493-502.
9. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007; 132: 1858-1862.
10. Manni R, Terzaghi M. Comorbidity between epilepsy and sleep disorders. Epilepsy Res 2010; 90: 171-177.
11. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004; 125: 112-117.
12. Dopp JM, Moran JJ, Abel NJ, Wiegert NA, Cowgill JB, Olson EB, et al. Influence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent model. Pharmacotherapy 2009; 29: 365-372.
13. Savransky V, Reinke C, Jun J, Bevans-Fonti S, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol 2009; 94: 228-239.
14. Zeng YM, Cai KJ, Chen XY, Wu MX, Lin X. Effect of chronic intermittent hypoxia on the expression of Nip3, cell apoptosis, β-amyloid protein deposit in mice brain cortex. Chin Med J 2009; 122: 68-73.
15. Riccalton-Banks L, Bhandari R, Fry J, Shakesheff KM. A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue. Mol Cell Biochem 2003; 248: 97-102.
16. Anzai H, Kamiya A, Shirato H, Takeuchi T, Miyajima A. Impaired differentiation of fetal hepatocytes in homozygous jumonji mice. Mech Dev 2003; 120: 791-800.
17. Omura T, Ssto R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its emoprotein nature. J Biol Chem 1964; 239: 2370-2378.
18. Fukushima S, Okuno H, Shibatani N, Nakahashi Y, Seki T, Okazaki K. Effect of biliary obstruction and internal biliary drainage on hepatic cytochrome P450 isozymes in rats. World J Gastroenterol 2008; 14: 2556-2560.
19. Jacobs MH, Senior RM, Kessler G. Clinical experience with theophylline. Relationships between dosage, serum concentration, and toxicity. JAMA 1976; 235: 1983-1986.
20. Wyatt R, Weinberger M, Hendeles L. Oral theophylline dosage for the management of chronic asthma. J Pediatr 1978; 92: 125-130.
21. Kurdi J, Maurice H, El-Kadi AO, Ong H, Dalkara S, Bélanger PM, et al. Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. Br J Pharmacol 1999; 128: 365-373.
22. Richer M, Lam YW. Hypoxia, arterial pH and theophylline disposition. Clin Pharmacokinet 1993; 25: 283-299.
23. du Souich P, Hoen B, Saunier C, Hartemann D, Sautegeau A, Cornette A, et al. Theophylline disposition in patients with COLD with and without hypoxemia. Chest 1989; 95: 1028-1032.
24. Streit M, Göggelmann C, Dehnert C, Burhenne J, Riedel KD, Menold E, et al. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). Eur J Clin Pharmacol 2005; 61: 39-46.
25. Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. Clin Pharmacol Ther 2006; 79: 489-499.
26. Marden NY, Fiala-Beer E, Xiang SH, Murray M. Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 2003; 373 (Pt 3): 669-680.
27. Earley S, Pastuszyn A, Walker BR. Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia. Am J Physiol Heart Circ Physiol 2003; 285: H127-H136.
28. Park EJ, Ko G, Kim J, Sohn DH. Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction. Arch Pharm Res 1999; 22: 60-67.
29. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.
30. Gude F, Rey-Garcia J, Fernandez-Merino C, Meijide L, García-Ortiz L, Zamarron C, et al. Serum levels of gamma-glutamyltransferase are associated with markers of nocturnal hypoxemia in a general adult population. Clin Chim Acta 2009; 407: 67-71.
31. Kheirandish-Gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 2008; 133: 92-99.
32. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 2007; 41: 918-921.
33. Verhulst SL, Jacobs S, Aerts L, Schrauwen N, Haentjens D, Rooman RP, et al. Sleep-disordered breathing: a new risk factor of suspected fatty liver disease in overweight children and adolescents? Sleep Breath 2009; 13: 207-210.
34. Savransky V, Reinke C, Jun J, Bevans-Fonti S, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol 2009; 94: 228-239.
35. Wu RH, Zeng YM, Chen XY. Intermittent hypoxia and isoniazid plus rifampicin affect hepatic ultrastructure in mice. Chin Med J 2011; 124: 4034-4038.
36. Zhu Y, Fenik P, Zhan G, Sanfillipo-Cohn B, Naidoo N, Veasey SC. Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J Neurosci 2008; 28: 2168-2178.